Differential effects of jaundice and cirrhosis on β-adrenoceptor signaling in three rat models of cirrhotic cardiomyopathy

Journal of Hepatology

Volumn 30, Issue 3, 1999, Pages 485-491

  Ma, Zenghua ^a   Zhang, Yikun ^a   Huet, P Michel ^b   Lee, Samuel S ^a  

^a UNIVERSITY OF CALGARY   (Canada)

^b UNIVERSITY OF MONTREAL   (Canada)

Author keywords

Adenylyl cyclase; Cardiovascular; Cirrhosis; Heart failure; Signal transduction

Indexed keywords

ADENYLATE CYCLASE; BETA ADRENERGIC RECEPTOR; THIOACETAMIDE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BETA ADRENERGIC STIMULATION; BILE DUCT LIGATION; CARDIOMYOPATHY; CHOLEDOCHOJEJUNOSTOMY; CONTROLLED STUDY; HEART FAILURE; HEART FUNCTION; HEART MUSCLE CONTRACTILE FORCE; HEART PAPILLARY MUSCLE; JAUNDICE; LIVER CIRRHOSIS; NONHUMAN; PORTOSYSTEMIC ANASTOMOSIS; PRIORITY JOURNAL; RAT; SHUNTING; SIGNAL TRANSDUCTION;

EID: 0033053958     PISSN: 01688278     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0168-8278(99)80109-3     Document Type: Article

References (28)

1. Abelmann WH, Kowalski HJ, McNeely WF. The hemodynamic response to exercise in patients with Laennec's cirrhosis. J Clin Invest. 34:1955;690-695.
2. Lee SS. Cardiac abnormalities in liver cirrhosis. West J Med. 151:1989;530-535.
3. Ma Z, Lee SS. Cirrhotic cardiomyopathy: getting to the heart of the matter. Heptology. 24:1996;451-459.
4. Rayes N, Bechstein WO, Keck H, Blumhardt G, Lohmann R, Neuhaus P. Cause of death after liver transplantation: an analysis of 41 cases in 382 patients. Zentralblatt Chir. 120:1995;435-438.
5. Pattynama PM, van Hoek B, Kool LJ. Inadvertent arteriovenous stenting during transjugular intrahepatic portosystemic shunt procedure and the importance of hepatic artery perfusion. Cardiovasc Intervent Radiol. 18:1995;192-195.
6. Binah O, Rubinstein I, Bomzon A, Bettor OS. Effects of bile acids on ventricular muscle contraction and electrophysiological properties: studies in rat papillary muscle and isolated ventricular myocytes. Arch Pharmacol. 335:1987;160-165.
7. LaRusso NF, Hoffman NE, Hoffmann AL, Kormann MG. Validity and sensitivity of an intravenous bile acid tolerance test in patients with liver disease. N Engl J Med. 292:1975;1209-1214.
8. Clain JE, Malagelada J, Chadwick VS, Hoffmann AE. Binding properties in vitro of antacid for conjugated bile acids. Gastroenterology. 73:1977;556-559.
9. Kountouras J, Billing BH, Scheuer PJ. Prolonged bile duct obstruction: a new experimental model for cirrhosis in the rat. Br J Exp Pathol. 65:1984;305-311.
10. Jalink D, Urbanski SJ, Lee SS. Bilioenteric anastomosis reverses hyperkinetic circulation in bile duct-ligated cirrhotic rats. J Hepatol. 24:1996;924-931.
11. Zimmermann T, Franke H, Dargel R. Studies on lipid and lipoprotein metabolism in rat liver cirrhosis induced by different regimens of thioacetamide administration. Exp Pathol. 30:1986;109-117.
12. 1-Adrenoceptor-mediated phosphoinositide breakdown and inotropic response in left ventricular papillary muscles. Circ Res. 62:1988;8-17.
13. 1 adenosine receptors in human myocardium. Am J Physiol. 266:1994;H1951-H1958.
14. Ma Z, Miyamoto A, Lee SS. Role of altered β-adrenergic receptor signal transduction in the pathogenesis of cirrhotic cardiomyopathy in rats. Gastroenterology. 110:1996;1191-1198.
15. St. Louis PJ, Sulakhe PV. Isolation of sarcolemmal membrane from cardiae muscle. Int J Biochem. 7:1976;547-558.
16. Ma Z, Meddings JB, Lee SS. Membrane physical properties determine cardiac β-adrenergic receptor function in cirrhotic rats. Am J Physiol. 267:1994;G87-G93.
17. Gilman AG. A protein binding assay for adenosine 3′,5′-cyclic monophosphate. Proc Natl Acad Sci USA. 67:1970;305-312.
18. Severson DL, Drummond GI, Sulakhe PV. Adenylate cyclase in skeletal muscle kinetic properties and hormonal stimulation. J Biol Chem. 247:1972;2949-2958.
19. Van Obbergh L, Vallieres Y, Blaise G. Cardiac modifications occurring in the ascitic rat with biliary cirrhosis are nitric oxide related. J Hepatol. 24:1996;747-752.
20. Ma Z, Lee SS, Meddings JB. Effects of altered cardiac membrane fluidity on β-adrenergic signalling function in rats with cirrhotic cardiomyopathy. J Hepatol. 26:1997;904-912.
21. Ward CR, Ma Z, Lee SS, Giles W. Potassium currents in atrial and ventricular myocytes from a rat model of cirrhosis. Am J Physiol. 273:1997;G537-G544.
22. Lumlertgol D, Boonyaprapa S, Bunnacheck D, Thanachaikun N, Praisontarangkul OA, Phornphutkul K, et al. The jaundiced heart: evidence for blunted response to positive inotropic stimulation. Renal Fail. 13:1991;15-22.
23. Jacob G, Nassar N, Hayam G, Ben-Haim S, Edoute Y, Better OS, et al. Cardiac function and responsiveness to β-adrenoceptor agonists in rats with obstructive jaundice. Am J Physiol. 265:1993;G314-G320.
24. Swain MG, MacArthur L, Vergalla J, Jones EA. Adrenal secretion of BAM-22P, a potent opioid peptide, is enhanced in rats with acute cholestasis. Am J Physiol. 266:1994;G201-G205.
25. Swain MG, Maric M. Tumor necrosis factor-α stimulates adrenal glucocorticoid secretion cholestatic rats. Am J Physiol. 270:1996;G987-G991.
26. Better OS, Bomzon A. Effects of jaundice on the renal and cardiovascular systems. Epstein M, . The Kidney in Liver Disease, 3rd ed. 1988;508-534 Williams & Wilkins, Baltimore.
27. Zavecz JH, Battarbee HD, Mercer J, Edwards R, Bueno O, Cady F. Impaired cardiac function in chronic portal vein-stenosed rats. [abstract] FASEB J. 9:1995;940A.
28. Gazawi H, Ljubuncic P, Meddings J, Bomzon A. Bile acids and hepatic cardiomyopathy. [abstract] J Hepatol. 25:1996;S174.